These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 16552773)

  • 1. Genetic background of different cancer cell lines influences the gene set involved in chromosome 8 mediated breast tumor suppression.
    Seitz S; Korsching E; Weimer J; Jacobsen A; Arnold N; Meindl A; Arnold W; Gustavus D; Klebig C; Petersen I; Scherneck S
    Genes Chromosomes Cancer; 2006 Jun; 45(6):612-27. PubMed ID: 16552773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A network of clinically and functionally relevant genes is involved in the reversion of the tumorigenic phenotype of MDA-MB-231 breast cancer cells after transfer of human chromosome 8.
    Seitz S; Frege R; Jacobsen A; Weimer J; Arnold W; von Haefen C; Niederacher D; Schmutzler R; Arnold N; Scherneck S
    Oncogene; 2005 Jan; 24(5):869-79. PubMed ID: 15580292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profile of differentially expressed genes after transfer of chromosome 17 into the breast cancer cell line CAL51.
    Klebig C; Seitz S; Korsching E; Kristiansen G; Gustavus D; Scherneck S; Petersen I
    Genes Chromosomes Cancer; 2005 Nov; 44(3):233-46. PubMed ID: 16049915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of MDA-MB-435 breast carcinoma cell metastasis following the introduction of human chromosome 11.
    Phillips KK; Welch DR; Miele ME; Lee JH; Wei LL; Weissman BE
    Cancer Res; 1996 Mar; 56(6):1222-7. PubMed ID: 8640802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
    Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8.
    Flanagan JM; Healey S; Young J; Whitehall V; Trott DA; Newbold RF; Chenevix-Trench G
    Genes Chromosomes Cancer; 2004 Jul; 40(3):247-60. PubMed ID: 15139003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma.
    Ko JM; Chan PL; Yau WL; Chan HK; Chan KC; Yu ZY; Kwong FM; Miller LD; Liu ET; Yang LC; Lo PH; Stanbridge EJ; Tang JC; Srivastava G; Tsao SW; Law S; Lung ML
    Mol Cancer Res; 2008 Apr; 6(4):592-603. PubMed ID: 18403638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
    Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
    J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis.
    Urquidi V; Sloan D; Kawai K; Agarwal D; Woodman AC; Tarin D; Goodison S
    Clin Cancer Res; 2002 Jan; 8(1):61-74. PubMed ID: 11801541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inserting chromosome 18 into pancreatic cancer cells switches them to a dormant metastatic phenotype.
    Lefter LP; Sunamura M; Furukawa T; Takeda K; Kotobuki N; Oshimura M; Matsuno S; Horii A
    Clin Cancer Res; 2003 Oct; 9(13):5044-52. PubMed ID: 14581380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer.
    Theile M; Seitz S; Arnold W; Jandrig B; Frege R; Schlag PM; Haensch W; Guski H; Winzer KJ; Barrett JC; Scherneck S
    Oncogene; 1996 Aug; 13(4):677-85. PubMed ID: 8761288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of tumorigenicity of rat liver tumor cells by human chromosome 13: evidence against the involvement of pRb and BRCA2.
    Rider MA; Butz GM; Ricketts SL; Newberry ST; Grisham JW; Coleman WB
    Int J Oncol; 2002 Feb; 20(2):235-45. PubMed ID: 11788883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.
    Wolf I; O'Kelly J; Rubinek T; Tong M; Nguyen A; Lin BT; Tai HH; Karlan BY; Koeffler HP
    Cancer Res; 2006 Aug; 66(15):7818-23. PubMed ID: 16885386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between reduction of metastasis in the MDA-MB-435 model system and increased expression of the Kai-1 protein.
    Phillips KK; White AE; Hicks DJ; Welch DR; Barrett JC; Wei LL; Weissman BE
    Mol Carcinog; 1998 Feb; 21(2):111-20. PubMed ID: 9496911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
    Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
    Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumorigenicity of human breast cancer is associated with loss of the Ca2+-activated chloride channel CLCA2.
    Gruber AD; Pauli BU
    Cancer Res; 1999 Nov; 59(21):5488-91. PubMed ID: 10554024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of {gamma}-aminobutyric acid type A receptor-associated protein, a novel tumor suppressor, showing reduced expression in breast cancer.
    Klebig C; Seitz S; Arnold W; Deutschmann N; Pacyna-Gengelbach M; Scherneck S; Petersen I
    Cancer Res; 2005 Jan; 65(2):394-400. PubMed ID: 15695379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of tumorigenicity of breast cancer cells by microcell-mediated chromosome transfer: studies on chromosomes 6 and 11.
    Negrini M; Sabbioni S; Possati L; Rattan S; Corallini A; Barbanti-Brodano G; Croce CM
    Cancer Res; 1994 Mar; 54(5):1331-6. PubMed ID: 8118824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.
    Horak CE; Lee JH; Elkahloun AG; Boissan M; Dumont S; Maga TK; Arnaud-Dabernat S; Palmieri D; Stetler-Stevenson WG; Lacombe ML; Meltzer PS; Steeg PS
    Cancer Res; 2007 Aug; 67(15):7238-46. PubMed ID: 17671192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.